NUVL
USDNuvalent Inc. Class A Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$94.250
Máximo
$95.225
Mínimo
$92.075
Volume
0.28M
Fundamentos da empresa
Capitalização de mercado
6.7B
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.46M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Nuvalent to Present Patient-Reported Outcomes Data from ARROS-1 Trial of ROS1-Selective Inhibitor, Zidesamtinib, at 2025 IASLC ASCO North America Conference on Lung Cancer
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
UBS Maintains Buy on Nuvalent, Raises Price Target to $132
UBS analyst David Dai maintains Nuvalent with a Buy and raises the price target from $114 to $132.
Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2025 Financial Results
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
Piper Sandler Maintains Overweight on Nuvalent, Raises Price Target to $128
Piper Sandler analyst Kelsey Goodwin maintains Nuvalent with a Overweight and raises the price target from $112 to $128.
Ações relacionadas
RNAC
Cartesian Therapeutics Inc.
FTAIN
FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares
HTIA
Healthcare Trust Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock
ABT
Abbott Laboratories
WDI
Western Asset Diversified Income Fund Common Shares of Beneficial Interest
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.